Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study of CND261 for Patients with Active ANCA-Positive Vasculitis That Has Not Responded to Previous Treatments

    Recruiting

    1 1
    Germany
  • A study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans

    Recruiting

    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark Finland France +8
  • A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Hungary +5
  • Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Spain
  • Testing 18F-DPA-714 PET scan as a marker of brain inflammation in patients with autoimmune encephalitis

    Recruiting

    1 1
    Investigated diseases:
    France
  • Study of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Italy
  • A Study of Sodium Selenite Followed by Chemotherapy in Patients with Advanced Cancer

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

    Recruiting

    Investigated drugs:
    Bulgaria Croatia France Germany Greece Hungary +5
  • Comparing 1-Minute and 5-Minute Poractant Alfa Treatment for Respiratory Distress Syndrome in Very Premature Babies Born Before 28 Weeks

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria